Dr Agarwals Eye Hsp Stock Price Analysis and Quick Research Report. Is Dr Agarwals Eye Hsp an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dr Agarwals Eye Hsp. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dr Agarwals Eye Hsp has a PE ratio of $$PE_ratio$$ which is #if ( $$PE_ratio$$ > 15 ) then "high" else "low";# and comparatively #if ( $$PE_ratio$$ > 15 ) then "overvalued" else "undervalued";#.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dr Agarwals Eye Hsp has ROA of $$ROA_Per$$% which is a #if ( $$ROA_Per$$ > 15 ) then "good" else "bad";# sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dr Agarwals Eye Hsp has a Current ratio of $$Current_Ratio_x$$.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dr Agarwals Eye Hsp has a ROE of 34.2785%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dr Agarwals Eye Hsp has a Debt to Equity ratio of 0.3264 which means that the company has #if ( 0.3264 > 2 ) then "high" else "low";# proportion of debt in its capital.

• Sales growth: Dr Agarwals Eye Hsp has reported revenue growth of $$NetSales_Growth_Y_1$$% which is #if( $$NetSales_Growth_Y_1$$ > 15 ) then "fair" else "poor";# in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dr Agarwals Eye Hsp for the current financial year is 28.8067647979956%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dr Agarwals Eye Hsp is Rs $$DPS_PCF_Y_1$$ and the yield is $$TTM_YIELD$$%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dr Agarwals Eye Hsp is Rs $$TTMEPS_Y_1$$. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dr Agarwals Eye Hsp in Ticker for free. Also, one can get the intrinsic value of Dr Agarwals Eye Hsp by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dr Agarwals Eye Hsp FAQs

Q1. What is Dr Agarwals Eye Hsp share price today?
Ans: The current share price of Dr Agarwals Eye Hsp is Rs 4465.

Q2. What is the market capitalisation of Dr Agarwals Eye Hsp?
Ans: Dr Agarwals Eye Hsp has a market capitalisation of Rs $$Market_Capitalisation$$ Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dr Agarwals Eye Hsp?
Ans: The PE ratio of Dr Agarwals Eye Hsp is $$PE_ratio$$ and the P/B ratio of Dr Agarwals Eye Hsp is $$PB_ratio$$, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dr Agarwals Eye Hsp share?
Ans: The 52-week high share price of Dr Agarwals Eye Hsp is Rs $$All_High$$, and the 52-week low share price of Dr Agarwals Eye Hsp is Rs $$All_Low$$.

Q5. Does Dr Agarwals Eye Hsp pay dividends?
Ans: Currently, Dr Agarwals Eye Hsp #if ( $$TTM_YIELD$$ > 0 ) then "pays" else "does not pay";# dividends. Dividend yield of Dr Agarwals Eye Hsp is around $$TTM_YIELD$$%.

Q6. What are the face value and book value of Dr Agarwals Eye Hsp shares?
Ans: The face value of Dr Agarwals Eye Hsp shares is Rs $$FV_Y_1$$, while the book value per share of Dr Agarwals Eye Hsp is around Rs $$TTMBook_NAV_Share$$. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dr Agarwals Eye Hsp?
Ans: Dr Agarwals Eye Hsp has a total debt of Rs $$Total_Debt$$ Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dr Agarwals Eye Hsp?
Ans: The ROE of Dr Agarwals Eye Hsp is 34.2785% and ROCE of Dr Agarwals Eye Hsp is $$ROCE_Y_1$$%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dr Agarwals Eye Hsp a good buy for the long term?
Ans: The Dr Agarwals Eye Hsp long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dr Agarwals Eye Hsp undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dr Agarwals Eye Hsp appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dr Agarwals Eye Hsp’s financials?
Ans: You can review Dr Agarwals Eye Hsp’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.